- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Venaxis Inc (APPY)
| Open: | 1.6500 | Day's Range: | 1.6500 - 1.6900 | Volume: | 41,048 |
|---|---|---|---|---|---|
| Previous Close: | 1.6500 | 52wk Range: | 1.1800 - 3.9600 | 1-Yr Rtn: | -49.70% |
Key Statistics for APPY
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -3.5800 |
| Est. EPS (USD) (12/2013) | -1.1600 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 16.52 |
| Shares Outstanding (M) | 9.95 |
| 30 Day Average Volume | 79,651 |
| Price/Book (mrq) | 1.4619 |
| Price/Sale (ttm) | 73.8019 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/24/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for APPY
Company Profile & Key Executives for APPY
Venaxis Inc is a biotechnology company. The Company's lead product focuses on a blood-based test designed to help physicians manage patients with abdominal pain and suspected of having acute appendicitis.
| Stephen T Lundy "Steve"President/CEO | Jeffrey G McGonegalCFO/Secretary |
| Donald R Hurd "Don"Chief Commercial Officer | Gregory S PuseyVP:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
APPY News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page